MedTrace Logo

Abdominal Aortic Aneurysm Patients Remain at Risk for Delirium on the Surgical Ward After Intensive Care Unit Dismissal

NCT04080557 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 135

Last updated 2019-09-06

No results posted yet for this study

Summary

The incidence of delirium following open abdominal aortic aneurysm (AAA) surgery is significant, with incidence rates ranging from 12 to 33%. The occurrence of delirium on the surgical ward after intensive care unit (ICU) dismissal in AAA patients remains unclear. Differences in outcomes between a delirium on the ICU and a delirium on the surgical ward have not been previously investigated.

Delirium is a frequent complication in patients who underwent open AAA surgery. This study demonstrated that patients on the surgical ward remain at risk for developing a delirium after ICU dismissal. Physicians should therefore maintain a high level of awareness for delirium in AAA patients who return to the surgical ward after ICU dismissal. This simultaneously emphasises the necessity of delirium preventive measures and early recognition on the surgical ward in order to improve clinical outcomes.

Conditions

  • Delirium
  • AAA
  • Intensive Care Unit Delirium
  • Surgery--Complications
  • Surgery
  • Aortic Aneurysm, Abdominal

Interventions

OTHER

Surgery

All patients treated electively for an abdominal aortic aneurysm (AAA) by open repair and patients undergoing emergency treatment for a ruptured AAA between 2013 and 2018.

Sponsors & Collaborators

  • Amphia Hospital

    lead OTHER

Principal Investigators

  • Lijckle van der Laan, MD, PhD · Amphia hospital Breda, the Netherlands

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-11-01
Primary Completion
2019-02-28
Completion
2019-02-28

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04080557 on ClinicalTrials.gov